Keith Bass
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,738 of the $31,054 with a category attached, or 82.9%. AbbVie accounts for 95.4% of it on its own, with 10 other manufacturers making up the rest. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $108.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Alkermes, Inc.$411
- Johnson & Johnson$305
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$279
- Axsome Therapeutics, Inc.$156
- Takeda Pharmaceuticals U.S.A., Inc.$78
- plus $191 from 5 others
What the payments were for
- Speaking & faculty fees$25,73883%
- Travel & lodging$1,5755%
- Food & beverage$3,74212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 196 | $29,636 |
| Alkermes, Inc. | 46 | $411 |
| Johnson & Johnson | 9 | $305 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $279 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $58 |
| Sunovion Pharmaceuticals Inc. | 4 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| USWM, LLC | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,054 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 342 | $521,900 |
| Invega SustennaPaliperidone Palmitate | 62 | $175,973 |
| AustedoDeutetrabenazine | 19 | $98,128 |
| RexultiBrexpiprazole | 68 | $75,744 |
| LybalviOlanzapine/Samidorphan Malate | 29 | $47,887 |
| TrintellixVortioxetine Hydrobromide | 60 | $31,155 |
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $19,378 |
| Aripiprazole | 322 | $14,828 |
| Paliperidone ErPaliperidone | 61 | $11,256 |
| Chlorpromazine Hcl | 23 | $10,225 |
| Clozapine | 44 | $10,158 |
| SeroquelQuetiapine Fumarate | 24 | $9,829 |
| Divalproex Sodium ErDivalproex Sodium | 161 | $8,904 |
| Lamotrigine | 730 | $8,638 |
| Fluvoxamine Maleate | 149 | $6,515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $29,636 | $521,900342 claims |
| Johnson & JohnsonInvega Sustenna | $305 | $175,97362 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $58 | $75,74468 claims |
| Alkermes, Inc.Lybalvi | $411 | $47,88729 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $78 | $31,15560 claims |
| Axsome Therapeutics, Inc.Auvelity | $156 | $19,37814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Anna
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.